Abstract

The literature on development has long underscored the importance of knowledge-based assets and innovation for economic growth and competitiveness. This paper explores an apparent paradox: why did Argentine regulators initially demur in approving the commercialization of genetically-modified (GM) wheat, one of very few products innovated by the country’s biotech sector? The answer lies in risk mitigation, but the risks Argentine regulators sought to avoid were not the environmental and health risks typically associated with GM products. Rather, they worried about possible disruptions to agricultural trade if exports were found to be contaminated by an unapproved GM product. I define the kind of risk that Argentine regulators sought to minimize as structural risk—that is, risk issuing from structural constraints a country faces given an unfavorable or dependent position in trade relations. By illuminating how risks emanating from structural constraints particular to Southern states shape regulatory frameworks, this analysis advances our understanding of the Regulatory State of the South.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call